Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

820 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure).
Felker GM, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Soergel DG, Teerlink JR, Violin JD, Voors AA, Pang PS. Felker GM, et al. Among authors: voors aa. JACC Heart Fail. 2015 Mar;3(3):193-201. doi: 10.1016/j.jchf.2014.09.008. Epub 2015 Jan 28. JACC Heart Fail. 2015. PMID: 25650371 Free article. Review.
High prevalence of microalbuminuria in chronic heart failure patients.
van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA. van de Wal RM, et al. Among authors: voors aa. J Card Fail. 2005 Oct;11(8):602-6. doi: 10.1016/j.cardfail.2005.05.007. J Card Fail. 2005. PMID: 16230263
Erythropoietin in chronic heart failure.
Belonje AM, Voors AA, van Gilst WH, van Veldhuisen DJ. Belonje AM, et al. Among authors: voors aa. Congest Heart Fail. 2007 Sep-Oct;13(5):289-92. doi: 10.1111/j.1527-5299.2007.06662.x. Congest Heart Fail. 2007. PMID: 17917496 Free article. Review.
Overview of emerging pharmacologic agents for acute heart failure syndromes.
De Luca L, Mebazaa A, Filippatos G, Parissis JT, Böhm M, Voors AA, Nieminen M, Zannad F, Rhodes A, El-Banayosy A, Dickstein K, Gheorghiade M. De Luca L, et al. Among authors: voors aa. Eur J Heart Fail. 2008 Feb;10(2):201-13. doi: 10.1016/j.ejheart.2008.01.002. Eur J Heart Fail. 2008. PMID: 18279775 Free article. Review.
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM; Protect Steering Committee, Investigators, and Coordinators. Cotter G, et al. J Card Fail. 2008 Oct;14(8):631-40. doi: 10.1016/j.cardfail.2008.08.010. Epub 2008 Sep 14. J Card Fail. 2008. PMID: 18926433 Clinical Trial.
820 results